-+ 0.00%
-+ 0.00%
-+ 0.00%

Gain Therapeutics FY2025 net loss per share narrows 31.46% to $0.61; cash, cash equivalents and marketable securities climb more than doubled to $20.8 million

Reuters·03/26/2026 11:04:15

Please log in to view news